Serum Thyroglobulin Doubling Time in Progressive Thyroid Cancer

Area of Science:

• Oncology
• Endocrinology
• Biomarker Research

Background:

• Tumor marker doubling time (DT) is a potential prognostic indicator in various cancers.
• This study investigates the DT of thyroglobulin (Tg), a thyroid-specific marker, in progressive differentiated thyroid cancer (DTC).

Purpose of the Study:

• To analyze the prognostic value of Tg doubling time (DT) in patients with progressive differentiated thyroid cancer (DTC).
• To compare Tg DT measurements using highly sensitive and conventional assays.
• To identify correlations between Tg DT, tumor load, and survival rates.

Main Methods:

• Retrospective analysis of 144 Tg courses from 99 patients with progressive or recurrent DTC.
• Tg DT was determined using both highly sensitive and routine assays.
• Uni- and multivariate statistical analyses were performed to assess survival predictors.

Main Results:

• The median Tg DT was 212 days, with no significant difference between assay types.
• Mortality risk was more than double for patients with Tg DT <5 months compared to Tg DT >14 months.
• Significant survival differences were observed only in patients with high tumor load (Tg >100 ng/mL).

Conclusions:

• Tg DT alone is not an independent survival predictor for all progressive DTC patients.
• Tg DT analysis reveals significant survival differences in progressive DTC patients with a high tumor load.